New Key Statistics Module, Z-Score and F-Score
OTCPK:XVIPF Key Ratios
| Market Cap $ M | 937.29 |
| Enterprise Value $ M | 916.60 |
| P/E(ttm) | 99.29 |
| PE Ratio without NRI | 99.29 |
| Forward PE Ratio | 97.63 |
| Price/Book | 4.01 |
| Price/Sales | 9.87 |
| Price/Free Cash Flow | 37.37 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 95.00 |
| EPS (TTM) $ | 0.30 |
| Beneish M-Score | -2.66 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 61.00 |
| EV-to-EBIT | 77.35 |
| EV-to-EBITDA | 77.35 |
| PEG | -- |
| Shares Outstanding M | 31.50 |
| Net Margin (%) | 9.89 |
| Operating Margin % | 12.47 |
| Pre-tax Margin (%) | 14.69 |
| Quick Ratio | 2.65 |
| Current Ratio | 3.86 |
| ROA % (ttm) | 3.65 |
| ROE % (ttm) | 4.15 |
| ROIC % (ttm) | 3.55 |
| Dividend Yield % | -- |
| Altman Z-Score | 17.19 |
XVIPF Number of Guru Trades
XVIPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:XVIPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:XVIPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xvivo Perfusion AB Insider Transactions
No Available Data
News about OTCPK:XVIPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers